Company Filing History:
Years Active: 2012
Title: Yanling Zhang: Innovator in Apoptosis Research
Introduction
Yanling Zhang is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of apoptosis research, particularly through her innovative work on inhibitors of Inhibitor of Apoptosis Proteins (IAPs). Her research focuses on developing novel compounds that can inhibit the binding of the Smac protein to IAPs, which has important implications for cancer therapy.
Latest Patents
Yanling Zhang holds 1 patent related to her groundbreaking work. The patent details the formula for inhibitors of IAPs, showcasing her commitment to advancing medical science and improving treatment options for patients.
Career Highlights
Currently, Yanling Zhang is employed at Novartis AG, a leading global healthcare company. Her role at Novartis allows her to collaborate with other experts in the field and contribute to the development of innovative therapies.
Collaborations
Throughout her career, Yanling has worked alongside notable colleagues, including Mark Gabriel Palermo and Sushil Kumar Sharma. These collaborations have further enriched her research and expanded the impact of her work in the scientific community.
Conclusion
In summary, Yanling Zhang is a dedicated inventor whose work on IAP inhibitors is paving the way for new cancer treatments. Her contributions to the field of apoptosis research are invaluable, and her collaboration with esteemed colleagues enhances the potential for future innovations.